Surgical Treatment of Gastric Cancer in a Community Hospital in Brazil: Who Are We Treating and How?
- First Online:
- Cite this article as:
- Nagem, R., Bicalho, L.G.M.F. & Lourenço, L.G. J Gastrointest Canc (2013) 44: 410. doi:10.1007/s12029-013-9516-4
- 88 Downloads
Surgical treatment of gastric cancer has risks, and the current trend in developed countries is to centralize cases in high-volume centers. Many countries, however, particularly the developing ones, have to rely in low-volume centers for the most part of gastric cancer operations. We aimed to verify the characteristics of the patients and tumors as well as the in-hospital outcomes in a community hospital in Brazil treating gastric cancer.
This is a retrospective study on patients undergoing surgical treatment of gastric adenocarcinoma at a community hospital in Brazil. The authors reviewed demographic, clinical, pathological, and perioperative data.
A total of 28 patients were operated on during the study period. Mean age was 69.5 years, 53.6 % were male, 67.9 % had anemia, 78.5 % had ASA score ≥ 3, 89.3 % were at nutritional risk, intestinal/diffuse ratio was 1.6, 68.5 % had tumor ≥ 6 cm, involvement of lower/middle third of the stomach occurred in 96.4 %, 73.7 % had serosal invasion, 79 % had stage III disease, median number of dissected nodes was 23, median operative time was 255 min, 21.4 % had urgent procedures, 67.8 % had curative surgery, 50 % had distal gastrectomy, 43.5 % had a Billroth I, median length of stay was 17 days, 53.6 % had some admission to the intensive care unit, 21.4 % required relaparotomy, 25 % had wound infection/dehiscence, and mortality was 66.7/18.2 % (urgent/non-urgent surgery).
We treat elderly malnourished patients with multiple comorbidities and advanced cancer. Improvement is required in lymph node dissection, non-surgical therapies, and critical care.